AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Combinatory Asthma Endoytping Assay

Summary

An easy-to-use test for a precise stratification of asthma patients, which facilitates a personalized and targeted selection of the best effective therapeutic antibody.

Technology Benefits

First diagnostic test for asthma endotyping that is relevant to the therapeutic strategy, particularly regarding the identification of the asthma subtype and the selection of the best suitable antibody
Easy-to-use and cost efficient
Compatible with existing laboratory equipment and routine

Technology Application

easy-to-use test for a more precise stratification of asthma patients and thus facilitates a personalized and better targeted therapeutic strategy

Detailed Technology Description

The invention is a PCR-based method for the differential diagnosis (combinatory transcriptomic endotyping) of asthma subtypes from blood (liquid biopsies). The method comprises the measurement of 32 RNA-biomarkers (including two house-keeping markers), a dedicated PCR microwellplate for the assay and a combinatory methodology including a software algorithm for analysis and determination of the asthma subtype.

Type of Cooperation

Licensing

Application Date

25/07/2019 00:00:00

Others

Patent application

ID No.

5224

Country/Region

Germany

For more information, please click Here